These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 19779861)

  • 1. Amplification and overexpression of KIT, PDGFRA, and VEGFR2 in medulloblastomas and primitive neuroectodermal tumors.
    Blom T; Roselli A; Häyry V; Tynninen O; Wartiovaara K; Korja M; Nordfors K; Haapasalo H; Nupponen NN
    J Neurooncol; 2010 Apr; 97(2):217-24. PubMed ID: 19779861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amplification of KIT, PDGFRA, VEGFR2, and EGFR in gliomas.
    Puputti M; Tynninen O; Sihto H; Blom T; Mäenpää H; Isola J; Paetau A; Joensuu H; Nupponen NN
    Mol Cancer Res; 2006 Dec; 4(12):927-34. PubMed ID: 17189383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amplification of genes encoding KIT, PDGFRalpha and VEGFR2 receptor tyrosine kinases is frequent in glioblastoma multiforme.
    Joensuu H; Puputti M; Sihto H; Tynninen O; Nupponen NN
    J Pathol; 2005 Oct; 207(2):224-31. PubMed ID: 16021678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of neurogenic basic helix-loop-helix genes in primitive neuroectodermal tumors.
    Rostomily RC; Bermingham-McDonogh O; Berger MS; Tapscott SJ; Reh TA; Olson JM
    Cancer Res; 1997 Aug; 57(16):3526-31. PubMed ID: 9270024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct phenotypic differences associated with differential amplification of receptor tyrosine kinase genes at 4q12 in glioblastoma.
    Burford A; Little SE; Jury A; Popov S; Laxton R; Doey L; Al-Sarraj S; Jürgensmeier JM; Jones C
    PLoS One; 2013; 8(8):e71777. PubMed ID: 23990986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of somatostatin receptors, P44/42 MAPK, and mTOR activation in medulloblastomas and primitive neuroectodermal tumors.
    Johnson MD; O'Connell MJ; Silberstein H; Korones D
    Appl Immunohistochem Mol Morphol; 2013 Dec; 21(6):532-8. PubMed ID: 23455179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-resolution array-based comparative genomic hybridization of medulloblastomas and supratentorial primitive neuroectodermal tumors.
    McCabe MG; Ichimura K; Liu L; Plant K; Bäcklund LM; Pearson DM; Collins VP
    J Neuropathol Exp Neurol; 2006 Jun; 65(6):549-61. PubMed ID: 16783165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in the human homologue of the Drosophila segment polarity gene patched (PTCH) in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system.
    Wolter M; Reifenberger J; Sommer C; Ruzicka T; Reifenberger G
    Cancer Res; 1997 Jul; 57(13):2581-5. PubMed ID: 9205058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prognostic analysis of pediatrics central nervous system small cell tumors: evaluation of EGFR family gene amplification and overexpression.
    Liu W; Zhang S; Zhang L; Cui Q; Wang J; Gui T; Pang Q
    Diagn Pathol; 2014 Jul; 9():132. PubMed ID: 24986561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of genetic and chromosomal aberrations in medulloblastomas and primitive neuroectodermal tumors with DNA microarrays.
    Kagawa N; Maruno M; Suzuki T; Hashiba T; Hashimoto N; Izumoto S; Yoshimine T
    Brain Tumor Pathol; 2006 Apr; 23(1):41-7. PubMed ID: 18095118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene amplification in PNETs/medulloblastomas: mapping of a novel amplified gene within the MYCN amplicon.
    Frühwald MC; O'Dorisio MS; Rush LJ; Reiter JL; Smiraglia DJ; Wenger G; Costello JF; White PS; Krahe R; Brodeur GM; Plass C
    J Med Genet; 2000 Jul; 37(7):501-9. PubMed ID: 10882752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of chromosome 17p deletions in childhood primitive neuroectodermal tumors (medulloblastomas) of the central nervous system.
    Biegel JA; Janss AJ; Raffel C; Sutton L; Rorke LB; Harper JM; Phillips PC
    Clin Cancer Res; 1997 Mar; 3(3):473-8. PubMed ID: 9815707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amplification of the PDGFRA, KIT and KDR genes in glioblastoma: a population-based study.
    Nobusawa S; Stawski R; Kim YH; Nakazato Y; Ohgaki H
    Neuropathology; 2011 Dec; 31(6):583-8. PubMed ID: 21382095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An investigation of WNT pathway activation and association with survival in central nervous system primitive neuroectodermal tumours (CNS PNET).
    Rogers HA; Miller S; Lowe J; Brundler MA; Coyle B; Grundy RG
    Br J Cancer; 2009 Apr; 100(8):1292-302. PubMed ID: 19293793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coexpression of platelet-derived growth factor alpha and beta receptors on medulloblastomas and other primitive neuroectodermal tumors is consistent with an immature stem cell and neuronal derivation.
    Smits A; van Grieken D; Hartman M; Lendahl U; Funa K; Nistér M
    Lab Invest; 1996 Jan; 74(1):188-98. PubMed ID: 8569181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant promoter methylation of previously unidentified target genes is a common abnormality in medulloblastomas--implications for tumor biology and potential clinical utility.
    Frühwald MC; O'Dorisio MS; Dai Z; Tanner SM; Balster DA; Gao X; Wright FA; Plass C
    Oncogene; 2001 Aug; 20(36):5033-42. PubMed ID: 11526488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PTEN and DMBT1 homozygous deletion and expression in medulloblastomas and supratentorial primitive neuroectodermal tumors.
    Inda MM; Mercapide J; Muñoz J; Coullin P; Danglot G; Tuñon T; Martínez-Peñuela JM; Rivera JM; Burgos JJ; Bernheim A; Castresana JS
    Oncol Rep; 2004 Dec; 12(6):1341-7. PubMed ID: 15547761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression, mutation and copy number analysis of platelet-derived growth factor receptor A (PDGFRA) and its ligand PDGFA in gliomas.
    Martinho O; Longatto-Filho A; Lambros MB; Martins A; Pinheiro C; Silva A; Pardal F; Amorim J; Mackay A; Milanezi F; Tamber N; Fenwick K; Ashworth A; Reis-Filho JS; Lopes JM; Reis RM
    Br J Cancer; 2009 Sep; 101(6):973-82. PubMed ID: 19707201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The three receptor tyrosine kinases c-KIT, VEGFR2 and PDGFRα, closely spaced at 4q12, show increased protein expression in triple-negative breast cancer.
    Jansson S; Bendahl PO; Grabau DA; Falck AK; Fernö M; Aaltonen K; Rydén L
    PLoS One; 2014; 9(7):e102176. PubMed ID: 25025175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Different hypermethylation status of RASSF1A in medulloblastoma and supratentorial primitive neuroectodermal tumor].
    Chang Q; Ng HK
    Zhonghua Bing Li Xue Za Zhi; 2007 Jan; 36(1):24-8. PubMed ID: 17374234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.